ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $608,000 | -33.9% | 9,837 | -35.8% | 0.01% | -40.0% |
| Q3 2019 | $920,000 | -22.3% | 15,312 | +9.1% | 0.02% | -21.1% |
| Q2 2019 | $1,184,000 | +216.6% | 14,035 | +258.0% | 0.02% | +137.5% |
| Q1 2019 | $374,000 | +37.0% | 3,920 | +1.7% | 0.01% | +33.3% |
| Q4 2018 | $273,000 | -6.8% | 3,853 | +12.3% | 0.01% | 0.0% |
| Q3 2018 | $293,000 | +2.1% | 3,430 | +38.5% | 0.01% | -14.3% |
| Q2 2018 | $287,000 | +23.7% | 2,476 | -13.8% | 0.01% | +40.0% |
| Q1 2018 | $232,000 | +182.9% | 2,873 | +62.1% | 0.01% | +150.0% |
| Q3 2017 | $82,000 | +24.2% | 1,772 | -3.2% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | -90.9% | 1,830 | -92.3% | 0.00% | -89.5% |
| Q1 2017 | $729,000 | +37.3% | 23,685 | +49.3% | 0.02% | +18.8% |
| Q4 2016 | $531,000 | +1029.8% | 15,860 | +797.6% | 0.02% | +700.0% |
| Q3 2016 | $47,000 | +38.2% | 1,767 | +14.7% | 0.00% | 0.0% |
| Q2 2016 | $34,000 | -24.4% | 1,540 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $45,000 | -22.4% | 1,540 | -12.4% | 0.00% | 0.0% |
| Q4 2015 | $58,000 | +7.4% | 1,758 | +18.5% | 0.00% | 0.0% |
| Q3 2015 | $54,000 | – | 1,483 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |